{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:08:54Z","timestamp":1784333334434,"version":"3.55.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ctro.2024.100885","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T07:05:06Z","timestamp":1731049506000},"page":"100885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Radiobiology and modelling in Brachytherapy: A review inspired by the ESTRO Brachytherapy pre-meeting course"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-1327","authenticated-orcid":false,"given":"A.J.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3062-8395","authenticated-orcid":false,"given":"A.","family":"Chyrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7659-7032","authenticated-orcid":false,"given":"J.L.","family":"Guinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.P.","family":"Hellebust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-9567","authenticated-orcid":false,"given":"P.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2815-8083","authenticated-orcid":false,"given":"C.","family":"Kirisits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tanderup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6771-6685","authenticated-orcid":false,"given":"D.","family":"Todor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wojcieszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Hannoun-Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2024.100885_b0005","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3322\/caac.21578","article-title":"Brachytherapy: An overview for clinicians","volume":"69","author":"Chargari","year":"2019","journal-title":"AC Cancer J Clin"},{"key":"10.1016\/j.ctro.2024.100885_b0010","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1259\/bjr\/31372149","article-title":"21 years of biologically effective dose","volume":"83","author":"Fowler","year":"2010","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2024.100885_b0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5114\/jcb.2012.27947","article-title":"Dose gradient impact on equivalent dose at 2 Gy for high dose rate interstitial brachytherapy","volume":"4","author":"Hannoun-Levi","year":"2012","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.ctro.2024.100885_b0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0360-3016(97)00096-5","article-title":"Calculation of integrated biological response in brachytherapy","volume":"38","author":"Dale","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2013.08.027","article-title":"Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses","volume":"109","author":"Sheu","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0167-8140(95)01695-3","article-title":"Constraints in the use of repair half times and mathematical modelling for the clinical application of HDR and PDR treatment schedules as an alternative for LDR brachytherapy","volume":"38","author":"Pop","year":"1996","journal-title":"Radiother Oncol"},{"issue":"71","key":"10.1016\/j.ctro.2024.100885_b0035","first-page":"3753","article-title":"Nine decades of radiobiology: is radiation therapy any the better for it?","volume":"1993","author":"The","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2024.100885_b0040","first-page":"431","article-title":"Disordance des effets de rayons X, d\u2019une part dans le testicule, par le fractionnement de la dose","volume":"97","author":"Regaud","year":"1927","journal-title":"Coniptes Rendus Societe Biologique"},{"key":"10.1016\/j.ctro.2024.100885_b0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semradonc.2019.08.009","article-title":"Radiobiology: Foundation and New Insights in Modeling Brachytherapy Effects","volume":"30","author":"Annede","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.canrad.2017.11.011","article-title":"Radiobiology of brachytherapy: The historical view based on linear quadratic model and perspectives for optimization","volume":"22","author":"Chargari","year":"2018","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ctro.2024.100885_b0055","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S1470-2045(19)30171-8","article-title":"Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy","volume":"20","author":"Deutsch","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0060","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3390\/cancers11060860","article-title":"The 6th R of Radiobiology: Reactivation of Anti-Tumor Immune Response","volume":"11","author":"Boustani","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2024.100885_b0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ijrobp.2023.09.027","article-title":"\u201cReinforcement\u201d by Tumor Microenvironment: The Seventh \u201cR\u201d of Radiobiology","volume":"119","author":"Taghizadeh-Hesary","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0070","article-title":"Radiation-induced bystander effect: the important part of ionizing radiation response. Potential clinical implications","volume":"63","author":"Wide\u0142","year":"2009","journal-title":"Postepy Hig Med Dosw (online)"},{"key":"10.1016\/j.ctro.2024.100885_b0075","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/028418698430043","article-title":"Comparison between fractionated high dose rate irradiation and continuous low dose rate irradiation in spheroids","volume":"37","author":"Omura","year":"1998","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0080","doi-asserted-by":"crossref","first-page":"49624","DOI":"10.1074\/jbc.M409600200","article-title":"Evasion of early cellular response mechanisms following low level radiation-induced DNA damage","volume":"279","author":"Collis","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ctro.2024.100885_b0085","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1080\/09553002.2017.1341661","article-title":"HDR brachytherapy decreases proliferation rate and cellular progression of a radioresistant human squamous cell carcinoma in vitro","volume":"93","author":"Geraldo","year":"2017","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ctro.2024.100885_b0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-9966-28-12","article-title":"The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells","volume":"28","author":"Zhuang","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ctro.2024.100885_b0095","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.ijrobp.2005.07.971","article-title":"Changes in the tumor microenvironment during low-dose-rate permanent seed implantation iodine-125 brachytherapy","volume":"63","author":"Cron","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0360-3016(00)00599-X","article-title":"Tumor hypoxia\u2014a confounding or exploitable factor in interstitial brachytherapy? Effects of tissue trauma in an experimental rat tumor model","volume":"48","author":"van den Berg","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0105","first-page":"2243","article-title":"Inhibition of glioblastoma growth and invasion by 125I brachytherapy in rat glioma model","volume":"9","author":"Chen","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.ctro.2024.100885_b0110","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.3390\/ijms21134585","article-title":"Brachytherapy in a Single Dose of 10Gy as an \u201cin situ\u201d Vaccination","volume":"21","author":"Jarosz-Biej","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ctro.2024.100885_b0115","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1186\/s12885-020-07403-1","article-title":"Relationship between the invasion of lymphocytes and cytokines in the tumor microenvironment and the interval after single brachytherapy hypofractionated radiotherapy and conventional fractionation radiotherapy in non-small cell lung Cancer","volume":"20","author":"Li","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2024.100885_b0120","series-title":"Basic Clinical Radiobiology","first-page":"106","article-title":"The linear quadratic approach to fractionation and calculation of isoeffect relationships","author":"Joiner","year":"1997"},{"key":"10.1016\/j.ctro.2024.100885_b0125","unstructured":"Radiobiology Textbook. Baatout S, ed.: Springer International Publishing; 2024."},{"key":"10.1016\/j.ctro.2024.100885_b0130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"van Leeuwen","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0135","article-title":"The linear quadratic model: usage, interpretation and challenges","author":"McMahon","year":"20186401","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2024.100885_b0140","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1259\/0007-1285-67-804-1231","article-title":"Non-uniform dwell times in line source high dose rate brachytherapy: physical and radiobiological considerations","volume":"67","author":"Jones","year":"1994","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2024.100885_b0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.radonc.2011.05.087","article-title":"The effect of alternative biological modelling parameters (\u03b1\/\u03b2 and half time of repair T \u00bd) on reported EQD2 values in the treatment of advanced cervical cancer","volume":"101","author":"De Leeuw","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0155","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clon.2022.02.009","article-title":"How Low Can You Go? The Radiobiology of Hypofractionation","volume":"34","author":"Brand","year":"2022","journal-title":"Clin Oncol (r Coll Radiol)"},{"key":"10.1016\/j.ctro.2024.100885_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109585","article-title":"Challenges of re-irradiation: A call to arms for physicists - and radiotherapy vendors","volume":"182","author":"Vasquez Osorio","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0165","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.canrad.2018.01.005","article-title":"Salvage brachytherapy as a modern reirradiation technique for local cancer failure: The Phoenix is reborn from its ashes","volume":"22","author":"Quivrin","year":"2018","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ctro.2024.100885_b0170","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.21037\/apm-24-4","article-title":"Re-irradiation practice and ESTRO\/EORTC consensus recommendations: 2023 ASTRO education panel","volume":"13","author":"Lee","year":"2024","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.ctro.2024.100885_b0175","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00345-024-05205-9","article-title":"Systematic review and recommendations for re-irradiation for intraprostatic radiorecurrent prostate cancer after definitive radiation therapy","volume":"42","author":"Saripalli","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.ctro.2024.100885_b0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2023.10.016","article-title":"Outcomes and toxicity in re-irradiation of gynecologic cancer: Systematic review of the Italian association of radiation and clinical oncology (AIRO)","volume":"179","author":"Critelli","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0185","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/cancers13061226","article-title":"Image-Guided Brachytherapy for Salvage Reirradiation: A Systematic Review","volume":"13","author":"Bockel","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2024.100885_b0190","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.3390\/cancers14174267","article-title":"An International Consensus on the Design of Prospective Clinical-Translational Trials in Spatially Fractionated Radiation Therapy for Advanced Gynecologic Cancer","volume":"14","author":"Amendola","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2024.100885_b0195","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0360-3016(96)00565-2","article-title":"Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues","volume":"37","author":"Fowler","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0200","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1259\/bjr.71.845.9691890","article-title":"The clinical radiobiology of brachytherapy","volume":"71","author":"Dale","year":"1998","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2024.100885_b0205","series-title":"Interstitial Brachytherapy","article-title":"Radiobiology of Brachytherapy","author":"Fu","year":"1990"},{"key":"10.1016\/j.ctro.2024.100885_b0210","first-page":"CD007563","article-title":"High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer","volume":"2014","author":"Liu","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ctro.2024.100885_b0215","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ijrobp.2003.11.040","article-title":"Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer","volume":"59","author":"Pos","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0220","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.ijrobp.2016.03.029","article-title":"The Curie-Da Vinci Connection: 5-Years' Experience With Laparoscopic (Robot-Assisted) Implantation for High-Dose-Rate Brachytherapy of Solitary T2 Bladder Tumors","volume":"95","author":"van der Steen-Banasik","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0225","article-title":"Brachytherapy boost in anal canal cancer - A GEC ESTRO PDR task force meta-analysis","volume":"39","author":"Annede","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0230","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/cancers13061459","article-title":"Image-Guided Adaptive Brachytherapy (IGABT) for Primary Vaginal Cancer: Results of the International Multicenter RetroEMBRAVE Cohort Study","volume":"13","author":"Westerveld","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2024.100885_b0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brachy.2023.10.002","article-title":"Redefining the role of pulsed-dose-rate brachytherapy in cervical cancer treatment using a preplanned approach","volume":"23","author":"Annede","year":"2024","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2024.100885_b0240","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.brachy.2015.08.010","article-title":"High-tech image-guided therapy versus low-tech, simple, cheap gynecologic brachytherapy","volume":"14","author":"Kirisits","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2024.100885_b0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"Potter","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0250","article-title":"ICRU Report 89: Prescribing, Recording and Reporting Brachytherapy for Cancer of the Cervix","volume":"13","author":"International Commission on Radiation Units and Measurements","year":"2013","journal-title":"J ICRU"},{"key":"10.1016\/j.ctro.2024.100885_b0255","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ijrobp.2008.03.032","article-title":"Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy","volume":"71","author":"Georg","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00066-021-01867-1","article-title":"The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry","volume":"198","author":"Major","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2024.100885_b0265","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.radonc.2015.07.028","article-title":"Feasibility of dominant intraprostatic lesion boosting using advanced photon-, proton- or brachytherapy","volume":"117","author":"Andrzejewski","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13014-023-02295-4","article-title":"Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT","volume":"18","author":"Benkhaled","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0275","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/ijgc-2019-000735","article-title":"Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy","volume":"30","author":"Lazzari","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ctro.2024.100885_b0280","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.brachy.2019.06.008","article-title":"Dosimetric and radiobiological investigation of permanent implant prostate brachytherapy based on Monte Carlo calculations","volume":"18","author":"Haidari","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2024.100885_b0285","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","article-title":"GEC\/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update","volume":"107","author":"Hoskins","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2021.12.047","article-title":"UROGEC group of GEC ESTRO with endorsement by the European Association of Urology. GEC-ESTRO ACROP prostate brachytherapy guidelines","volume":"167","author":"Henry","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0295","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.brachy.2022.02.003","article-title":"Brachytherapy focal dose escalation using ultrasound based tissue characterization by patients with non-metastatic prostate cancer: Five-year results from single-center phase 2 trial","volume":"21","author":"Strnad","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2024.100885_b0300","unstructured":"Definition of fractionation. National Cancer Institute. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/fractionation. Access on line 06\/04\/24."},{"key":"10.1016\/j.ctro.2024.100885_b0305","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brachy.2019.02.008","article-title":"Compendium of fractionation choices for gynecologic HDR brachytherapy-An American Brachytherapy Society Task Group Report","volume":"18","author":"Albuquerque","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2024.100885_b0310","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1259\/0007-1285-60-711-301","article-title":"What minimum number of fractions is required with high dose rate remote afterloading?","volume":"60","author":"Dale","year":"1987","journal-title":"Brit J Radiol"},{"key":"10.1016\/j.ctro.2024.100885_b0315","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0360-3016(00)00810-5","article-title":"High dose rate brachytherapy may be radiobiologically superior to low dose rate due to slow repair of late responding normal tissue cells","volume":"49","author":"Orton","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0320","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2307\/3580085","article-title":"Is repair of DNA strand break damage from ionizing radiation second-order rather than first-order? A simpler explanation of apparently multiexponential repair","volume":"152","author":"Fowler","year":"1999","journal-title":"Radiat Res"},{"key":"10.1016\/j.ctro.2024.100885_b0325","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2018.01.013","article-title":"GEC-ESTRO ACROP recommendations in skin brachytherapy","volume":"126","author":"Guinot","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110217","article-title":"Very accelerated partial breast irradiation in 1 or 2 days: Late toxicity and early oncological outcome of the GEC-ESTRO VAPBI cohort","volume":"194","author":"Hannoun-Levi","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0335","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5114\/jcb.2022.121477","article-title":"Single-fraction high-dose-rate brachytherapy: a scoping review on outcomes and toxicities for all disease sites","volume":"14","author":"Kazemi","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.ctro.2024.100885_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110426","article-title":"Single-dose high-dose-rate brachytherapy versus two and three fractions for locally advanced prostate cancer","volume":"199","author":"Hoskin","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0345","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.radonc.2020.02.009","article-title":"Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy","volume":"146","author":"Morton","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0350","doi-asserted-by":"crossref","first-page":"e1101206","DOI":"10.1080\/2162402X.2015.1101206","article-title":"The dual role of NK cells in antitumor reactions triggered by ionizing radiation in combination with hyperthermia","volume":"2","author":"Finkel","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ctro.2024.100885_b0355","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0360","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semradonc.2020.05.008","article-title":"Evidence-based dose planning aims and dose prescription in image-guided brachytherapy combined with radiochemotherapy in locally advanced cervical cancer","volume":"30","author":"Tanderup","year":"2020","journal-title":"Sem Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0365","article-title":"MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy","volume":"110263","author":"Skipar","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0370","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2016.05.014","article-title":"Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer","volume":"120","author":"Tanderup","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0375","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/02841860410002824","article-title":"The radiobiology of prostate cancer including new aspects of fractionated radiotherapy","volume":"44","author":"Fowler","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0380","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.brachy.2020.10.009","article-title":"HDR brachytherapy as monotherapy for prostate cancer: A systematic review with meta-analysis","volume":"20","author":"Viani","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2024.100885_b0385","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.brachy.2023.03.003","article-title":"Radiobiological evaluation of the stepping-source effect in single-fraction monotherapy high-dose-rate prostate brachytherapy","volume":"22","author":"Tien","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2024.100885_b0390","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijrobp.2020.01.010","article-title":"Diminishing Returns From Ultrahypofractionated Radiation Therapy for Prostate Cancer","volume":"107","author":"Vogelius","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0395","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0360-3016(96)00579-2","article-title":"Cell kinetic measurements in prostate cancer","volume":"37","author":"Haustermans","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0400","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijrobp.2012.11.033","article-title":"Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer","volume":"85","author":"Pedicini","year":"2013","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0405","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1158\/1078-0432.CCR-11-2711","article-title":"Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer","volume":"18","author":"Milosevic","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctro.2024.100885_b0410","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.breast.2023.04.006","article-title":"Hypofractionation: The standard for external beam breast irradiation","volume":"69","author":"Brunt","year":"2023","journal-title":"Breast"},{"key":"10.1016\/j.ctro.2024.100885_b0415","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1158\/1078-0432.CCR-07-4453","article-title":"Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding","volume":"14","author":"Belletti","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctro.2024.100885_b0420","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2013.06.030","article-title":"Equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator","volume":"108","author":"Stewart","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0425","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.ijrobp.2004.05.072","article-title":"Biologic comparison of partial breast irradiation protocols","volume":"60","author":"Rosenstein","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0430","series-title":"Radiotherapy Treatment Planning Linear-Quadratic Radiobiology","author":"Chapman","year":"2015"},{"key":"10.1016\/j.ctro.2024.100885_b0435","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2017.08.011","article-title":"Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis","volume":"125","author":"Zaorsky","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0440","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2024.100885_b0445","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1118\/1.2358205","article-title":"The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor sub volumes","volume":"33","author":"Ruggieri","year":"2006","journal-title":"Med Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0450","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0360-3016(95)02124-T","article-title":"Time factor for tonsillar carcinoma","volume":"33","author":"Thames","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0455","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/ijc.34801","article-title":"Low-dose radiation therapy mobilizes antitumor immunity: New findings and future perspectives","volume":"154","author":"Zhou","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctro.2024.100885_b0460","article-title":"Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8","author":"Walle","year":"202284050","journal-title":"Sci Adv"},{"key":"10.1016\/j.ctro.2024.100885_b0465","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijrobp.2019.02.025","article-title":"Optimized Hypofractionation Can Markedly Improve Tumor Control and Decrease Late Effects for Head and Neck Cancer","volume":"104","author":"Shuryak","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0470","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0167-8140(92)80142-6","article-title":"Dosimetry of intraluminal brachytherapy","volume":"23","author":"Marinello","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0475","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0140-6736(04)17272-3","article-title":"Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial","volume":"364","author":"Homs","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2024.100885_b0480","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1442-2050.2005.00467.x","article-title":"Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial","volume":"18","author":"Bergquist","year":"2005","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ctro.2024.100885_b0485","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","article-title":"Radiation Dose-Response Model for Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy","volume":"85","author":"Appelt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100885_b0490","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.1088\/0031-9155\/53\/24\/008","article-title":"Calculation of relative biological effectiveness of a low-energy electronic brachytherapy source","volume":"53","author":"Reniers","year":"2008","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2024.100885_b0495","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial","volume":"8","author":"Gerard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ctro.2024.100885_b0500","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.brachy.2022.08.004","article-title":"Endorectal contact radiation boosting: Making the case for dose AND volume reporting","volume":"21","author":"Van Limbergen","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2024.100885_b0505","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2021.07.021","article-title":"A multi-centre analysis of adjuvant contact X-Ray brachytherapy (CXB) in rectal cancer patients treated with local excision-preliminary results of the CONTEM1 study","volume":"162","author":"Dhadda","year":"2021","journal-title":"Radiother and Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0510","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s00066-023-02103-8","article-title":"Crosstalk between immune checkpoint and DNA damage response inhibitors for radiosensitization of tumors","volume":"199","author":"Classen","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2024.100885_b0515","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.radonc.2019.01.034","article-title":"Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study","volume":"133","author":"Rijkmans","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100885_b0520","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.canrad.2022.07.001","article-title":"Clinical applications of high dose rate endorectal brachytherapy for patients with rectal cancer","volume":"26","author":"Vuong","year":"2022","journal-title":"Cancer Radiother"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824001629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824001629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T23:31:15Z","timestamp":1733959875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630824001629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":104,"alternative-id":["S2405630824001629"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100885","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiobiology and modelling in Brachytherapy: A review inspired by the ESTRO Brachytherapy pre-meeting course","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100885"}}